Ventus Raises $100m To Take First Novel Compounds Into Clinic

Company Quiet About Initial Targets, Except For NLRP3

 
• By Mandy Jackson
  
Virtual business assistant illustration
Ventus raised $100m to fuel its technology platform and small molecule pipeline growth • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business